For decades, dog owners juggled multiple products to keep their pets free from parasites. A topical spot-on for fleas, a separate oral pill for heartworm, another product for intestinal worms - the routine was exhausting and easy to disrupt. That fragmented approach is now giving way to something far more practical. Afoxolaner and milbemycin oxime chewable tablets represent a genuine shift in how veterinary professionals and pet owners think about parasite management, delivering broad-spectrum protection through a single monthly dose that dogs actually want to eat.
This article breaks down what sets this combination product apart, how it targets a wide range of parasites, and why it has become a go-to solution for comprehensive canine care worldwide.
Afoxolaner And Milbemycin Oxime Chewable Tablets
1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablet
9.375+1.875mg：2-3.5kg
18.75+3.75mg：＞3.5-7.5kg
37.5+7.5mg：＞7.5-15kg
75+15mg：＞15-30kg
150+30mg：＞30-60kg
(3)Ointment
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-2-117
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Xi'an Factory
What Makes Afoxolaner and Milbemycin Oxime Chewable Tablets Different From Traditional Deworming Options?
A Dual-Action Formula That Works on Two Fronts
Most conventional deworming methods target just one kind of parasite, either internal or external. Afoxolaner and milbemycin oxime chewable tablets are a novel combination of two distinct chemicals that function in various ways, in one pleasant tablet. The isoxazoline chemical afoxolaner, a blocker of GABA-gated chloride channels in arthropods. This overstimulates their neural systems and kills fleas, ticks, and mites. Milbemycin oxime is a macrolide anthelmintic that opens the glutamate-gated chloride channels of invertebrate nerve and muscle cells. This will paralyze and hyperpolarize internal parasites like as heartworms and stomach nematodes.
The combination works very well since the compounds don't interfere with one another's activity.
Oral Convenience With Proven Bioavailability
Older methods of parasite management frequently included topical medicines that required dogs to keep dry for lengthy periods or injectables that needed vet visits. These chewable pills solve both difficulties. Afoxolaner is 100% accessible in dogs when administered orally, with maximum blood levels being reached within two to four hours. Milbemycin oxime, portions A3 and A4, have half-lives of 1.6 and 3.3 days, respectively, and peak levels are reached in 1 to 2 hours. The plasma half-life of afoxolaner is about two weeks, thereby providing continued protection against ectoparasites throughout the month.
Single-agent traditional products merely don't have that pharmacokinetic profile.
Afoxolaner and Milbemycin Oxime Chewable Tablets for Multiple Intestinal Worm Targets
Broad Nematode Coverage in a Single Monthly Dose
Gastrointestinal parasitism is still one of the most common health problems dogs face around the world. Roundworms, hookworms, and whipworms are very dangerous, especially for puppies and animals with weak immune systems. This problem is immediately fixed by the milbemycin oxime component of afoxolaner and milbemycin oxime chewable tablets. Milbemycin oxime paralyzes adult nematodes and their larvae permanently by binding to glutamate-gated chloride channels that are only found in invertebrate nerve and muscle tissue. Veterinary pharmacology studies that have been published confirm that milbemycin oxime works against the larvae of Toxocara canis,
Ancylostoma caninum, Trichuris vulpis, and Dirofilaria immitis.These are the most common types of intestinal and cardiovascular worms found in pets.
Heartworm Prevention as a Core Benefit
Dirofilaria immitis is the causative agent of heartworm disease, an extremely severe illness for dogs in several regions of Europe, North America, South America, and Asia. The product's value proposition is in part based on the ability of milbemycin oxime to halt heartworm larval growth. This combo pill, when taken as directed once a month, kills third- and fourth-stage heartworms before they may mature into adults. This stops the transmission cycle.
This added function makes the medication not just a dewormer but a true multi-system parasite shield that defends against the animal's main parasite danger and also manages gut worms.
How Do These Chewable Tablets Expand Canine Parasite Control Beyond Deworming?
The Role of Afoxolaner in External Parasite Elimination
The milbemycin oxime portion wipes out internal parasites, while the afoxolaner part kills fleas and ticks swiftly and for a long time. Afoxolaner is highly selective for GABA-gated chloride channels specifically in arthropods. To do so, it exploits the structural distinctions between insect and human receptors. Research has revealed that afoxolaner begins killing fleas eight hours after application and kills virtually all of them within 24 hours. The chemical begins to act against ixodid ticks within 48 hours. This rapid killing rate is important for medicine since it decreases the time ticks may transmit illnesses such as Borrelia burgdorferi and Anaplasma phagocytophilum.
Expanding Protection to Mites and Mange
Afoxolaner's isoxazoline mechanism makes it effective against more than just fleas and ticks. It also kills some types of mites. Sarcoptic mange, which is caused by Sarcoptes scabiei, and demodicosis, which is caused by Demodex canis, are both hard-to-treat conditions that used to take a long time to work. Studies in veterinary journals that have been reviewed by experts have shown that isoxazoline chemicals, such as afoxolaner, can help dogs with both sarcoptic and demodectic mange. Because it targets more ectoparasites, a single monthly afoxolaner and milbemycin oxime chewable tablet can treat conditions that used to need different, and often difficult to follow, treatment plans.
Afoxolaner and Milbemycin Oxime Chewable Tablets for Integrated Flea, Tick and Worm Management
Why Integration Matters for Real-World Pet Care
In real life, fleas, ticks, and intestinal worms all come into contact with dogs at the same time. If you treat each danger with a different product, it's more likely that people won't follow through with your treatment plan. This could happen if they forget to take their doses, forget which product they last used, or don't realize how much the parasite seasons overlap. Taking afoxolaner and milbemycin oxime chewable tablets together once a month simplifies this process into a single, time-based schedule. Veterinary compliance research regularly shows that easier dosing plans lead to better adherence.
This means that animals will be better protected against parasites and healthier over time.
Weight-Based Dosing for Dogs Across All Life Stages
The product comes in five different dose levels based on dog weight, ranging from 2 kg to over 30 kg. This fine-grained specification method makes sure that each animal gets the right amount for its needs-not too little, which could mean that the treatment doesn't work, nor too much, which could be dangerous. For afoxolaner, the dose range is determined to be between 2.5 mg/kg and 6.9 mg/kg. For milbemycin oxime, there is an appropriately measured ratio for each tablet size.Because of this, the product works for both small toy breeds and large working dogs,
making it a great choice for households with more than one dog and veterinary clinics.
Can Afoxolaner and Milbemycin Oxime Chewable Tablets Simplify Comprehensive Parasite Care for Dogs?
Palatability as a Practical Advantage
One problem that isn't thought about enough when it comes to controlling parasites is how hard it is to give dogs medicine. When you put on topical products, they cause stress. People often don't accept plain pills that are hidden in food. This combination product immediately handles that problem with its chewable form. Since the tablets are made to taste good, most dogs will take them on their own, which takes away the hassle of giving them medicine the old-fashioned way. This rate of acceptance has measurable benefits further down the line: owners are more likely to keep up with monthly dosing when it is easy,
and dogs get the security they need without showing anxiety or avoidance behavior.
Safety Profile Across Breeds and Life Stages
This excellent receptor selectivity of both active compounds is responsible for the favorable safety profile of the product. Afoxolaner has a very high affinity for insect GABA receptors and very low affinity for mammalian receptors, whereas milbemycin oxime has a very poor affinity for penetrating the mammalian blood-brain barrier. Dogs with a minimum weight of 2kg and no more than eight weeks old may apply. Collie-type breeds with the MDR1 gene mutation should be treated with caution since this mutation alters how medications are metabolized.
Pregnant or nursing animals should consult with their vet. For those outside these categories, there is a good safety record for the product, so you may use it without concern for a long period as part of a routine health maintenance regimen.
Conclusion
The introduction of afoxolaner and milbemycin oxime chewable tablets is a real turning point in the treatment of parasites in animals. By combining two pharmacologically different active ingredients into one tasty pill, this product fixes the problems with inefficiency, compliance, and coverage that have long plagued traditional deworming methods. The dual-mechanism mixture protects against heartworms, eradicates fleas and ticks, and controls intestinal nematodes and fleas. It does all of this with just one monthly dose. This combination tablet sets a new bar for ease of use, accuracy, and proven effectiveness for veterinary workers, pet owners, and pharmaceutical procurement teams alike.
Frequently Asked Questions
1. What parasites do afoxolaner and milbemycin oxime chewable tablets treat?
+
-
The two-in-one protection these tablets offer protects against both external and internal parasites. Milbemycin oxime kills heartworm larvae, roundworms, hookworms, and whipworms, and afoxolaner kills fleas, ticks, and mites. Altogether, they cover the most dangerous parasites that dogs have.
2. How often should afoxolaner and milbemycin oxime chewable tablets be administered?
+
-
It is suggested that the dose be taken once a month. The pharmacokinetic profiles of both compounds, especially afoxolaner's plasma half-life of about two weeks, are meant to keep protective drug levels steady over the 30-day period, making sure that parasites are always controlled between doses.
3. Are afoxolaner and milbemycin oxime chewable tablets safe for all dog breeds?
+
-
Most dogs that are at least eight weeks old and weigh at least two kilograms can use the product. Milbemycin oxime may not work the same way in dogs with the MDR1 gene variation, which is common in Collie-type breeds. A vet should check these dogs out before using it. Also, pregnant or nursing dogs need to be checked out by a vet before they are given the medicine.
Partner With Bloomtechz for Reliable Afoxolaner and Milbemycin Oxime Chewable Tablets Supply
If your business needs a reliable supplier of afoxolaner and milbemycin oxime chewable tablets, Bloomtechz can meet your needs for quality assurance and supply consistency. With over 100,000 square meters of space and certifications from the US FDA, the EU, Japan, and the CFDA, our GMP-certified production center has helped 24 foreign pharmaceutical and R&D clients from North America, Europe, Asia-Pacific, and other places. There are three strict steps we use to make sure the quality of our products: factory inspection, in-house QC/QA analysis, and testing by qualified Chinese officials who are not part of our company. Our product line includes both standard specs and fully customized OEM/ODM formulations. We also prepare paperwork packages to make it easier for your products to get through customs in the market you want to reach. Bloomtechz has been making organic and fine chemicals for more than 12 years and has both deep technical knowledge and quick customer service. Talk to us today to find out why buyers from all over the world trust us.
Contact our team directly: Sales@bloomtechz.com.
References
1. Taenzler, J., et al. "Efficacy of afoxolaner against Otodectes cynotis infestations in dogs."
2. Drag, M., et al. "Comparative speed of kill of afoxolaner (NexGard®) and milbemycin oxime against induced infestations of Ixodes ricinus in dogs."
3. Prichard, R., & Geary, T. "Perspectives on the utility of moxidectin and related macrolides for the control of parasitic nematodes in the face of developing anthelmintic resistance."
4. Six, R.H., et al. "Efficacy and safety of afoxolaner, a new isoxazoline compound, in a dose-confirmation field study for the treatment of generalized demodicosis in dogs."
5. Wengenmayer, C., et al. "The speed of kill of afoxolaner (NexGard®) against Ctenocephalides felis and Ctenocephalides canis on dogs."
6. Carithers, D., et al. "Preventive efficacy of combined afoxolaner and milbemycin oxime against heartworm disease in dogs."